What the Top Ten epilepsy research priorities mean for the UK research ecosystem.
Journal Information
Full Title: EBioMedicine
Abbreviation: EBioMedicine
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Genetics, Medical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of interests Rhys H Thomas has received honoraria from Angelini/Arvelle, Bial, Biocodex, Eisai, Jazz/GW Pharma, NeuraxPharm, Sanofi, Takeda, UCB Pharma, UNEEG, Zogenix, and unrestricted research funding from Angelini/Arvelle and UNEEG. The UK Epilepsy Priority Setting Partnership (PSP) was funded, led and managed by the Epilepsy Research Institute UK (formerly Epilepsy Research UK). The Epilepsy Research Institute UK is a company registered in England and Wales with company number 4873718. Registered office: Churchill House, 35 Red Lion Square, London, WC1R 4SG."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025